BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24285100)

  • 21. Current management of pediatric thyroid disease and differentiated thyroid cancer.
    Tracy ET; Roman SA
    Curr Opin Oncol; 2016 Jan; 28(1):37-42. PubMed ID: 26575691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Death from thyroid cancer of follicular cell origin.
    Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
    J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study.
    Klein Hesselink EN; Klein Hesselink MS; de Bock GH; Gansevoort RT; Bakker SJ; Vredeveld EJ; van der Horst-Schrivers AN; van der Horst IC; Kamphuisen PW; Plukker JT; Links TP; Lefrandt JD
    J Clin Oncol; 2013 Nov; 31(32):4046-53. PubMed ID: 24101052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
    PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
    Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
    Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of thyroglobulin measurement with fine-needle aspiration biopsy for lymph node metastases in patients with a history of differentiated thyroid cancer.
    Zhang HS; Wang RJ; Fu QF; Gao S; Sun BT; Sun H; Ma QJ
    Asian Pac J Cancer Prev; 2014; 15(24):10905-9. PubMed ID: 25605199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience.
    Kim SS; Lee BJ; Lee JC; Song SH; Kim BH; Son SM; Kim IJ; Kim YK; Kang YH
    Endocrine; 2011 Jun; 39(3):259-65. PubMed ID: 21161440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis.
    Hammad MO; Elabbasy LM; Abd Elghaffar MA; Zaki MMA; Bazeed FB; Zahran MA
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e154-e161. PubMed ID: 30884127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.
    Böhm J; Kosma VM; Eskelinen M; Hollmen S; Niskanen M; Tulla H; Alhava E; Niskanen L
    Eur J Endocrinol; 1999 Nov; 141(5):460-7. PubMed ID: 10576761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging
    Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N
    Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients.
    Taboni S; Paderno A; Giordano D; Albano D; Piana S; Zanetti E; Bertagna F; Grammatica A; Ghidini A; Cappelli C; Bozzola A; Baronchelli C; Nicolai P; Lombardi D
    Laryngoscope; 2021 Mar; 131(3):E1029-E1034. PubMed ID: 33319385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor aggressiveness risk factors in the differentiated thyroid carcinoma.
    Lukas J; Hitnausova B; Jiskra J; Syrucek M
    Bratisl Lek Listy; 2016; 117(2):91-3. PubMed ID: 26830039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence.
    Pingpank JF; Sasson AR; Hanlon AL; Friedman CD; Ridge JA
    Arch Otolaryngol Head Neck Surg; 2002 Nov; 128(11):1275-8. PubMed ID: 12431169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-treatment surveillance of thyroid cancer.
    Wang LY; Ganly I
    Eur J Surg Oncol; 2018 Mar; 44(3):357-366. PubMed ID: 28754228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
    Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
    McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
    Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.